Indian Pharma Sector Can Grow to $450 Billion By 2047: OPPI Report

As per joint EY Parthenon-Organisation of Pharmaceutical Producers of India (OPPI) report, the Indian pharmaceutical industry can grow to $450 billion by 2047 as a result of transformative innovation, fortification of manufacturing and quality...

Sanjivani Paranteral and HAL Ink Partnership To Produce IV formulations

Sanjivani Paranteral Limited, a prominent pharmaceutical firm specializing in the production and sale of high-quality parenteral and oral solid products, has entered into a substantial deal with Hindustan Antibiotics Limited for the production of...

Simcere Pharma Partners with Connect Biopharma For Innovation

Simcere Pharmaceutical Group Limited signed into an exclusive licensing and partnership agreement with Connect Biopharma HongKong Limited In respect to Rademikibart, a novel IL-4R monoclonal antibody. Pursuant to the Agreement, Simcere obtains...

SK Bioscience and Hilleman Lab Sign Pact To Improve Vaccine Access

SK Bioscience, an innovative vaccine and biotech company dedicated to promoting human health from prevention to cure, has announced a development licensing agreement with Hilleman Laboratories, a vaccines and biologics research and development...

US FDA Approves Senhwa's Phase II IND Application of Silmitasertib

Senhwa Biosciences, Inc., a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced that the US Food and Drug Administration has approved Silmitasertib (CX-4945)'s phase II...

Lupin Bags USFDA Nod For Cholesterol Lowering Drug Pitavastatin

Lupin Limited has announced that the United States Food and Drug Administration (US FDA) has approved its Abbreviated New Drug Application for Pitavastatin Tablets, 1 mg, 2 mg, and 4 mg, to market a generic equivalent of Kowa Company Limited's...

Merck to Acquire Caraway Therapeutics For $610 Million

Merck, known as MSD outside the United States and Canada, and Caraway Therapeutics, Inc. announced a definitive agreement in which Merck, through a subsidiary, will acquire Caraway Therapeutics for a total potential consideration of up to...

Silo Pharma and Medspray Enter into Agreement For PTSD Treatment

Silo Pharma, Inc., a developmental stage biopharmaceutical company focused on combining traditional therapeutics with psychedelic research, announced a new exclusive license agreement with medical technology manufacturer Medspray Pharma BV for its...

Lupin Secures US Regulator Approval For Diabetes Drug

Lupin stated that its abbreviated new drug application for Dapagliflozin Tablets has gained preliminary clearance from the US Food and Drug Administration. The medications are prescribed to patients with type 2 diabetes. The company said that the...

WHO Introduces New Guideline To Address Malnutrition in children

With the release of its new guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition), the World Health Organization (WHO) is furthering the worldwide fight against acute malnutrition in children under the...

© 2024 India Pharma Outlook. All Rights Reserved.